talactoferrin alfa has been researched along with Local Neoplasm Recurrence in 1 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
| Excerpt | Relevance | Reference |
|---|---|---|
| "Talactoferrin alfa (TLF) is a unique recombinant form of human lactoferrin." | 1.40 | Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients. ( Bhattacharya, N; Blenman, KR; Engleman, E; Hwang, G; Lee, PP; Malik, R; Neal, JW; Pultar, P; Riess, JW; San-Pedro Salcedo, M; Wakelee, HA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riess, JW | 1 |
| Bhattacharya, N | 1 |
| Blenman, KR | 1 |
| Neal, JW | 1 |
| Hwang, G | 1 |
| Pultar, P | 1 |
| San-Pedro Salcedo, M | 1 |
| Engleman, E | 1 |
| Lee, PP | 1 |
| Malik, R | 1 |
| Wakelee, HA | 1 |
1 other study available for talactoferrin alfa and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lactoferrin; Lung Neoplasms; Male; Middle Aged | 2014 |